Financial results for the period ended September 30, 2026
As filed · Syngene International Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
EarningsMajormateriality 75 out of 100
What happened
FactFinancial results for the period ended September 30, 2026. The Board of Directors, at its meeting.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Demand
RevisedEarlierQ4 FY25
Q4 growth was broad based across research, development and manufacturing services, underpinning full year growth of 4% on a reported basis and 2% in constant currency.
NowQ4 FY25
Syngene reported revenue growth of 11% year-on-year, and 8% sequentially crossing the Rs. 1,000 Cr in a quarter threshold for the first time.
Change
FactTarget revision
Implication
CapitSignal interpretationThe earlier statement indicated a full year growth of 4% on a reported basis, while the current statement reports a revenue growth of 11% year-on-year for Q4 FY25.
Watch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- Looking at the year ahead, while the wider global market dynamics remain uncertain, we expect the business mom (management committed by FY26)
- We are maintaining our annual guidance for revenue for FY26. (management committed by FY26)
Evidence
- Syngene International Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.(opens the original filing in a new tab)
- Earlier statement · Q4 FY25
- Latest statement · Q4 FY25
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +2 corroborating keywords; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%